Filorexant has been used in trials studying the prevention and treatment of Migraine, Headache, Polysomnography, Diabetic Neuropathy, Painful, and Major Depressive Disorder, Recurrent. Its therapeutic use is listed as central nervous system (CNS) agents. The directory classifies it as a discontinued API with a synthetic source/manufacturing origin. Other names for this substance include Filorexantum and MK6096. Its PubChem CID is 25128145.
Filorexant
| CAS No | 1088991-73-4 |
|---|---|
| Molecular Formula | C24H25FN4O2 |
| Molecular Weight | 420.5 g/mol |
| Synonyms | [(2R,5R)-5-[(5-fluoro-2-pyridinyl)oxymethyl]-2-methylpiperidin-1-yl]-(5-methyl-2-pyrimidin-2-ylphenyl)methanone |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Filorexant has been used in trials studying the prevention and treatment of Migraine, Headache, Polysomnography, Diabetic Neuropathy, Painful, and Major Depressive Disorder, Recurrent.
The listed CAS number is 1088991-73-4.
The listed molecular formula is C24H25FN4O2.
The listed molecular weight is 420.5 g/mol.
[(2R,5R)-5-[(5-fluoro-2-pyridinyl)oxymethyl]-2-methylpiperidin-1-yl]-(5-methyl-2-pyrimidin-2-ylphenyl)methanone.
The source lists Filorexantum and MK6096.